ZVSA insider transaction filings

ZyVersa Therapeutics, Inc. — 8 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2025-07-16. Screen ZVSA transaction legs live →

FiledFormInsiderReported transactionsSource
2025-07-164Cashmere Karen A. — Chief Commercial OfficerGrant/award (A): 48,100 (derivative) @ $0EDGAR
2025-07-154Wolfe Peter — Chief Financial OfficerGrant/award (A): 60,100 (derivative) @ $0EDGAR
2025-07-154Park Min-Chul — DirectorGrant/award (A): 11,066 (derivative) @ $0EDGAR
2025-07-154Guzman Pablo A. — Chief Medical OfficerGrant/award (A): 48,900 (derivative) @ $0EDGAR
2025-07-154SAPIRSTEIN JAMES — DirectorGrant/award (A): 11,066 (derivative) @ $0EDGAR
2025-07-154Finizio Robert G — DirectorGrant/award (A): 11,066 (derivative) @ $0EDGAR
2025-07-154Freitag Gregory Gene — DirectorGrant/award (A): 11,066 (derivative) @ $0EDGAR
2025-07-154Glover Stephen C. — Chief Executive Officer, DirectorGrant/award (A): 136,900 (derivative) @ $0EDGAR

Recent 8-K events — ZyVersa Therapeutics, Inc.

FiledFormItems reportedSource
2026-07-168-K8.01 — Other EventsEDGAR
2026-07-108-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
8.01 — Other Events
EDGAR
2026-03-058-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2025-12-038-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2025-11-198-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2025-10-158-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2025-09-188-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2025-07-288-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2025-07-168-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
9.01 — Financial Statements and Exhibits
EDGAR
2025-07-098-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=ZVSA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →